Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

180.08
Delayed Data
As of Apr 24
 -4.50 / -2.44%
Today’s Change
147.81
Today|||52-Week Range
203.30
-2.68%
Year-to-Date

Today’s Trading

Previous close184.58
Today’s open183.04
Day’s range179.52 - 183.98
Volume1,644,938
Average volume (3 months)1,274,559
Market cap$36.8B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+12.94%
Earnings growth (next 5 years)+21.19%
Revenue growth (last year)+46.49%
P/E ratio55.3
Price/Sales16.55
Price/Book11.13

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+2.37+3.22%
VRTXVertex Pharmaceutica...-2.62-1.93%
PRGOPerrigo Company PLC-8.74-4.33%
ZTSZoetis Inc+0.86+1.83%
Data as of 4:00pm ET, 04/24/2015

Financials

Last reporting dateApril 23, 2015
EPS forecast (this quarter)$1.33
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers